Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.

Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N, OPTIMAS investigators

Open source

DOI
10.1016/s0140-6736(24)02197-4
Published
2024 Oct 23
Container
Lancet (London, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-24-02197-4,
  title = {Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.},
  author = {Werring DJ and Dehbi HM and Ahmed N and Arram L and Best JG and Balogun M and Bennett K and Bordea E and Caverly E and Chau M and Cohen H and Cullen M and Doré CJ and Engelter ST and Fenner R and Ford GA and Gill A and Hunter R and James M and Jayanthi A and Lip GYH and Massingham S and Murray ML and Mazurczak I and Nash PS and Ndoutoumou A and Norrving B and Sims H and Sprigg N and Vanniyasingam T and Freemantle N and OPTIMAS investigators},
  year = {2024},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(24)02197-4},
  url = {https://doi.org/10.1016/s0140-6736(24)02197-4}
}

RIS

TY  - JOUR
TI  - Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
AU  - Werring DJ
AU  - Dehbi HM
AU  - Ahmed N
AU  - Arram L
AU  - Best JG
AU  - Balogun M
AU  - Bennett K
AU  - Bordea E
AU  - Caverly E
AU  - Chau M
AU  - Cohen H
AU  - Cullen M
AU  - Doré CJ
AU  - Engelter ST
AU  - Fenner R
AU  - Ford GA
AU  - Gill A
AU  - Hunter R
AU  - James M
AU  - Jayanthi A
AU  - Lip GYH
AU  - Massingham S
AU  - Murray ML
AU  - Mazurczak I
AU  - Nash PS
AU  - Ndoutoumou A
AU  - Norrving B
AU  - Sims H
AU  - Sprigg N
AU  - Vanniyasingam T
AU  - Freemantle N
AU  - OPTIMAS investigators
PY  - 2024
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(24)02197-4
UR  - https://doi.org/10.1016/s0140-6736(24)02197-4
ER  - 

APA

DJ, W., HM, D., N, A., L, A., JG, B., M, B., K, B., E, B., E, C., M, C., H, C., M, C., CJ, D., ST, E., R, F., GA, F., A, G., R, H., M, J., A, J., GYH, L., S, M., ML, M., I, M., PS, N., A, N., B, N., H, S., N, S., T, V., N, F., & investigators, O. (2024). Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)02197-4

Source records